3.0.0 2210 2023-01-11T20:20:27Z 2023-01-11T20:20:27Z Senate S S 2007-10-19 110 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2007-10-19T16:38:10Z 2007-10-19 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2007-10-19 Introduced in Senate IntroReferral 10000 9 Library of Congress S000033 Sen. Sanders, Bernard [I-VT] Bernard Sanders I VT N Health Auditing Awards, medals, prizes Commemorations Commerce Communicable diseases Congress Congressional investigations Cost effectiveness Drug approvals Drug industry Economics and Public Finance Finance and Financial Sector Intellectual property Marketing Medical innovations Orphan drugs Patents Pharmaceutical research Research and development Revolving funds Science, Technology, Communications Vaccines Health 00 2007-10-19 Introduced in Senate 2008-03-04T22:57:44Z Medical Innovation Prize Act of 2007 - Prohibits any person from having the right to exclusively manufacture, distribute, sell, or use in interstate commerce a drug, a biological product, or a drug or biological product manufacturing process, including the exclusive right to rely on health registration data or the 30-month stay-of-effectiveness period for Orange Book patents under the Federal Food, Drug, and Cosmetic Act, notwithstanding provisions of that Act and other specified laws.

Establishes the Fund for Medical Innovation Prizes. Requires the Board of Trustees for the Fund to award prize payments for medical innovations relating to a drug, biological product, or manufacturing process. Requires an eligible award recipient to be either the first person to receive market clearance or the holder of the patent. Directs the Board to consider: (1) the number of patients who benefited from the drug, including non-U.S. patients; (2) the incremental therapeutic benefit of the drug to treat the same disease or condition, except that the Board shall provide for cases where drugs, biological products, or manufacturing processes are developed at roughly the same time so that the comparison is to products that were not recently developed; (3) the degree to which the drug addresses priority health care needs, such as global infectious diseases and neglected diseases that primarily afflict the poor in developing countries; and (4) the improved efficiency of manufacturing processes for drugs or biological processes. Allows the Board to award prize payments for no more than ten years. Allocates certain minimum payments from the Fund for priority research and development.

Requires the Comptroller General to conduct an audit to determine the Board's effectiveness in bringing to market new drugs, vaccines, biological products, and manufacturing processes in a cost-effective manner and in addressing society's global medical needs.

]]> Medical Innovation Prize Act of 2007 Official Title as Introduced A bill to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes. Introduced in Senate IS Display Title Medical Innovation Prize Act of 2007 Short Titles as Introduced Medical Innovation Prize Act of 2007 Introduced in Senate 2007-10-19T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-110s2210is/xml/BILLS-110s2210is.xml 2007-10-19 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.